Return to homepagePandemic Pact

Use of therapeutic drug monitoring (TDM) to optimise oral/enteral hydroxychloroquine dosing in critically ill patients with COVID-19

  • Funded by Australian Government (Australian Research Council)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $308,348.27

  • Funder

    Australian Government (Australian Research Council)

  • Principal Investigator

    N/A

  • Research Location

    Australia

  • Lead Research Institution

    Queensland University of Technology

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Prophylactic use of treatments

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

MRFF Respiratory Medicine Clinical Trials Research on COVID-19 Grant Opportunity research recipient